5 Underperforming Stocks Targeted By Short Sellers

3. Intercept Pharmaceuticals Inc (NASDAQ: ICPT)

Short % of Float (Jan 14, 2021): 34.23%

Short % of Shares Outstanding (Jan 14, 2021): 21.59%

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) develops novel synthetic bile acid analogs to treat chronic liver diseases like primary biliary cirrhosis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension and bile acid diarrhea. The company’s primary product is 6-ethyl-chenodeoxycholic acid or INT-747, marketed as Ocaliva.

The stock is down more than 62% in the last 12 months. As of the end of the September quarter, 20 hedge funds tracked by Insider Monkey held stakes in the company.